Comparison of changing autopsy trends in the Bronx population with acquired immunodeficiency syndrome

Modern Pathology

Volumn 9, Issue 10, 1996, Pages 1001-1006

  Concepcion, Lydia ^a   Markowitz, Glen S ^a   Borczuk, Alain C ^a   Factor, Stephen M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS; Autopsy; Bronchopneumonia; Pneumocystis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOPSY; CANCER; CAUSE OF DEATH; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AUTOPSY; CAUSE OF DEATH; FEMALE; HUMANS; MALE; NEW YORK CITY; PREVALENCE; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0029957559     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gottlieb MS, Schroff R, Schanker HM, et al.: Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: Evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425, 1981
2. Centers for Disease Control and Prevention: First 500,000 AIDS Cases: United States, 1995. MMWR Morb Mortal Wkly Rep 44:849, 1995
3. Drucker E, Vermund SH: Estimating population prevalence of HIV infection in urban areas with high rates of intravenous drug use: A model of the Bronx in 1988. Am J Epidemiol 130:133, 1989
4. Nicolosi A, Leite MLC, Musicco M: Parental and sexual transmission of HIV in intravenous drug use: A study of seroconversion. Am J Epidemiol 135:225, 1992
5. Klatt EC, Nichols L, Noguchi TT: Evolving trends revealed by autopsies of patients with acquired immunodeficiency syndrome: 565 autopsies in adults with AIDS, Los Angeles, CA, 1982-1993. Arch Pathol Lab Med 118:884, 1994
6. Hoover DR, Saah AJ, Bacellar N, et al.: Clinical manifestations of AIDS in the era of PCP prophylaxis. N Engl J Med 329:1922, 1993
7. Nightingale SD, Cameron DW, Gordin FM, et al.: Two controlled trials of Rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 329:823, 1993
8. Frieden TR, Sterling T, Pablos-Mendez A, et al.: Emergence of drug resistant tuberculosis in New York City. N Engl J Med 328:521, 1993
9. Reichert CM, O'Leary TJ, Levens DL, Simrell CR, Macher AM: Autopsy pathology in AIDS. Am J Pathol 112:357, 1983
10. Hui AN, Koss MN, Meyer PR: Necropsy findings in AIDS: A comparison of premortem diagnoses with postmortem findings. Hum Pathol 15:670, 1984
11. Wilkes MS, Jacobs TA, Milberg J, Stoneburner R: Autopsy patterns of patients dying in New York City. Arch Pathol Lab Med 112:1221, 1988
12. Centers for Disease Control and Prevention: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36(Suppl):3S, 1987
13. Centers for Disease Control and Prevention: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recommendations and Reports 41:1, 1992
14. Hirsh MS: Chemotherapy of human immunodeficiency virus infections: Current practice and future prospects. J Infect Dis 161:845, 1990
15. Vella S, Giulano M, Pezzotti P, et al.: Survival of zidovudine treated patients compared with that of contemporary untreated patients. JAMA 267:1232, 1992
16. Centers for Disease Control and Prevention: Update: AIDS among women - United States, 1994. JAMA 273:767, 1995
17. Valdiserri RO, Aultman TV, Curran JW: Community planning: A national strategy to improve HIV prevention programs. J Commun Health 20:87, 1995
18. Centers for Disease Control and Prevention: External Review of the CDC's HIV Prevention Strategies by the CDC Advisory Committee on the Prevention of HIV Infection. United States Department of Health and Human Services, Public Health Services, Centers for Disease Control and Prevention, 1994
19. Graham NM, Zeger SL, Park LP, et al.: The effects on survival of early treatment of HIV infection. N Engl J Med 326:1037, 1992
20. Jenson BN, Nielson TL, Backer V, et al.: Aerosolized pentamidine for primary prophylaxis of PCP: A controlled randomized trial. J AIDS 6:472, 1993
21. Osmond D, Charlebois E, Lang W, Shibolski S, Moss A: Changes in survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 271:1121, 1994
22. Lidman C, Berglund O, Tynell E, Lindback S, Elvin K: Aerosolized pentamidine as primary prophylaxis for PCP: Efficacy, mortality and morbidity. AIDS 8:935, 1994
23. Holmberg S, Conley, Buchbinder SP, et al.: Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three U.S. cities. AIDS 7:699, 1993
24. Gallant JE, McAvinue SM, Moore RD, et al.: The impact of prophylaxis on outcome and resource utilization in PCP. Chest 107:1018, 1995
25. Crawford JT: Epidemiology of tuberculosis: The impact of HIV and multidrug resistant strains. Immunobiology 191:337, 1994
26. Hirschtick RE, Glassroth J, Jordan MC, et al: Bacterial pneumonia in persons infected with HIV. N Engl J Med 333:845, 1995
27. Centers for Disease Control and Prevention: First 100,000 cases of AIDS: United States. MMWR Morb Mortal Wkly Rep 38:229, 1989
28. Karon JM, Berkelman RL: The geographic and ethnic diversity of AIDS incidence trends in homosexual and bisexual men in the U.S. J AIDS 4:1179, 1991
29. Centers for Disease Control and Prevention: Update: AIDS associated with intravenous drug use - United States. MMWR Morb Mortal Wkly Rep 38:165, 1988
30. Schrager L, Friedland G, Fiener C, Kahl P: Demographic characteristics, drug use, and sexual behavior of IV drug users with AIDs in the Bronx. Public Health Rep 106:78, 1991
31. Anonymous: An international comparative study of HIV prevalence and risk behaviors among drug injectors in 13 cities. Bull Narc 45:19, 1993
32. Des Jarlais DC: The 1993 Okey Memorial Lecture. Cross-national studies of AIDS among injecting drug users. Addiction 98:383, 1994